In regards to the insurance benefit expansion of high-price antibodies, is it ‘special treatment’ or ‘natural procedure’?

Antibodies are typically more expensive than regular drugs. Thus, a number of patients have requested higher insurance guarantee, but due to uncertainty of their effectiveness per price, antibodies are treatments receiving closely 50% of their cost.

Although price reduction of antibodies may improve effectiveness over price, it is not that easy to have price negotiation as most costly antibodi...